Veterinary Medicines

EFFIPRO 67 MG SOLUTION POUR SPOT-ON POUR PETITS CHIENS

Authorised
  • Fipronil
Download as PDF

Product identification

Medicine name:
EFFIPRO 67 MG SOLUTION POUR SPOT-ON POUR PETITS CHIENS
Effipro 67 mg kožni nanos, raztopina za majhne pse
Active substance:
  • Fipronil
Target species:
  • Dog
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Fipronil
    67.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Withdrawal period by route of administration:
  • Cutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX15
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovenia
Package description:
  • Boîte de 150 plaquettes thermoformées de 1 pipette de 0,67 mL
  • Boîte de 90 plaquettes thermoformées de 1 pipette de 0,67 mL
  • Boîte de 60 plaquettes thermoformées de 1 pipette de 0,67 mL
  • Boîte de 30 plaquettes thermoformées de 1 pipette de 0,67 mL
  • Boîte de 24 plaquettes thermoformées de 1 pipette de 0,67 mL
  • Boîte de 12 plaquettes thermoformées de 1 pipette de 0,67 mL
  • Boîte de 8 plaquettes thermoformées de 1 pipette de 0,67 mL
  • Boîte de 6 plaquettes thermoformées de 1 pipette de 0,67 mL
  • Boîte de 4 plaquettes thermoformées de 1 pipette de 0,67 mL
  • Boîte de 2 plaquettes thermoformées de 1 pipette de 0,67 mL
  • Boîte de 1 plaquette thermoformée de 1 pipette de 0,67 mL
  • Boîte de 150 pipettes de 0,67 mL
  • Boîte de 90 pipettes de 0,67 mL
  • Boîte de 60 pipettes de 0,67 mL
  • Boîte de 30 pipettes de 0,67 mL
  • Boîte de 24 pipettes de 0,67 mL
  • Boîte de 12 pipettes de 0,67 mL
  • Boîte de 8 pipettes de 0,67 mL
  • Boîte de 6 pipettes de 0,67 mL
  • Boîte de 4 pipettes de 0,67 mL
  • Boîte de 3 pipettes de 0,67 mL
  • Boîte de 2 pipettes de 0,67 mL
  • Boîte de 1 pipette de 0,67 mL

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
  • DC/V/0104/006
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0377/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 23/03/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 23/03/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 23/03/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."